Clinical trial
A 2-Part Capillary Blood Biomarker Cohort Study to Diagnose Adolescent Sport Concussion
NCT05287997 is registered in ClinicalTrials.gov with Neurolytixs as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 2-Part Capillary Blood Biomarker Cohort Study to Diagnose Adolescent Sport Concussion
- Lead sponsor
- Neurolytixs
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2022
- Completion date
- December 31, 2023
- Enrollment
- 150 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.